PP
PRVA icon

PDT Partners’s Privia Health PRVA Stock Holding History

PDT Partners’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.79M Sell
184,479
-37,500
-17% -$845K 0.22% 151
2025
Q4 		$5.26M Buy
221,979
+3,300
+2% +$80.3K 0.34% 92
2025
Q3 		$5.45M Hold
218,679
– – 0.34% 84
2025
Q2 		$5.03M Buy
218,679
+132,180
+153% +$3.06M 0.28% 106
2025
Q1 		$1.94M Buy
+86,499
New +$2.01M 0.14% 260
2024
Q2 		– Sell
-58,096
Closed -$1.14M – 730
2024
Q1 		$1.14M Sell
58,096
-36,305
-38% -$767K 0.11% 306
2023
Q4 		$2.17M Sell
94,401
-23,349
-20% -$523K 0.24% 132
2023
Q3 		$2.71M Buy
117,750
+29,401
+33% +$748K 0.34% 83
2023
Q2 		$2.31M Sell
88,349
-28,007
-24% -$740K 0.32% 98
2023
Q1 		$3.21M Hold
116,356
– – 0.44% 59
2022
Q4 		$2.64M Buy
116,356
+44,462
+62% +$1.24M 0.43% 46
2022
Q3 		$2.45M Sell
71,894
-40,809
-36% -$1.51M 0.37% 45
2022
Q2 		$3.28M Buy
112,703
+66,443
+144% +$1.69M 0.29% 70
2022
Q1 		$1.24M Sell
46,260
-17,787
-28% -$420K 0.11% 304
2021
Q4 		$1.66M Buy
64,047
+53,348
+499% +$1.33M 0.13% 263
2021
Q3 		$252K Buy
+10,699
New +$374K 0.02% 636

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PDT Partners's PRVA Position: Q1 2026 in Review

PDT Partners reduced its Privia Health (PRVA) stake by 17% in Q1 2026, selling an estimated $845K and leaving 184,479 shares worth $3.79M. The position accounts for 0.22% of the portfolio, ranked #151.

PDT Partners first reported a position in PRVA in Q3 2021 and has held it in 16 quarters since. The position peaked at $5.45M in Q3 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • PDT Partners held 184,479 shares of Privia Health worth $3.79M as of Q1 2026.
  • PDT Partners sold 37,500 Privia Health shares in Q1 2026, an estimated $845K.
  • Privia Health made up 0.22% of PDT Partners's portfolio in Q1 2026, its #151 holding.
  • PDT Partners first reported a position in Privia Health in Q3 2021 and has held it in 16 quarters since.
  • PDT Partners's Privia Health position peaked at $5.45M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.